PharmaShots | Incisive News in 3 Shots

Subscribe Now

azacytidine

AbbVie's Venclyxto Receives the EC's Approval for Patients with Newly Diagnosed Acute Myeloid Leukemia who are Ineligible for Intensive Chemotherapy

AbbVie's Venclyxto Receives the EC's Approval for Patients with Newly Diagnosed Acute Myeloid Leukemia who are Ineligible for Inte...

May 26, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us